Akseli Hemminki

55PUBLICATIONS
61CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsLiquid biopsiesPredictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (55)

|Nov 02, 2026
Effects of Concomitant Medications on Clinical and Immunological Outcomes of Cancer Patients Treated With Oncolytic Adenoviruses.

|Oct 01, 2026
Three-generation familial risks in early-onset prostate cancer with maternal and paternal relatives.

|Aug 20, 2026
Immune-cytokine signature predicts survival in patients with advanced melanoma treated with oncolytic adenovirus TILT-123 and chemotherapy and IL-2-free adoptive TIL therapy.

|Feb 26, 2026
Increase in second primary lung cancers in a nation-wide cohort study from Sweden.

Frantisek Zitricky, Kristina Sundquist, Jan Sundquist

|Nov 29, 2025
Second Primary Lung Cancer Associated With Family History of Lung Cancer.

Frantisek Zitricky, Kristina Sundquist, Jan Sundquist

|Apr 10, 2025
Single-cell profiling of peripheral blood mononuclear cells from patients treated with oncolytic adenovirus TILT-123 reveals baseline immune status as a predictor of therapy outcomes.

Tatiana V Kudling, Dmitrii Bychkov, James H A Clubb

Pageof 10

Frequent Collaborators

30 joint publications

Kari Hemminki

14 joint publications

Asta Försti

9 joint publications

Santeri Pakola

8 joint publications

Guoqiao Zheng